Oncolytics Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 21, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	143	103	132	131	96	131
Market Cap Growth	-	-22.52%	0.96%	36.08%	-26.39%	-19.30%
Enterprise Value	129	84	93	99	49	105
Last Close Price	1.42	1.33	1.79	2.22	1.75	3.02
PB Ratio	23.40	17.13	4.80	4.95	2.67	5.29
P/TBV Ratio	23.40	17.13	4.80	4.95	2.67	5.29
Debt / Equity Ratio	0.15	0.18	0.02	0.01	0.02	0.02
Quick Ratio	2.24	2.39	8.24	8.15	15.37	11.56
Current Ratio	2.88	2.82	9.01	9.05	16.69	12.45
Return on Equity (ROE)	-249.28%	-189.05%	-102.66%	-79.34%	-86.45%	-182.63%
Return on Assets (ROA)	-74.56%	-74.11%	-55.46%	-40.44%	-40.88%	-58.93%
Return on Invested Capital (ROIC)	-146.95%	-124.82%	-76.99%	-52.89%	-52.97%	-124.54%
Earnings Yield	-21.34%	-30.93%	-20.98%	-18.95%	-27.32%	-17.20%
FCF Yield	-17.32%	-26.54%	-21.51%	-17.86%	-23.59%	-16.89%
Buyback Yield / Dilution	-11.95%	-13.10%	-16.53%	-8.44%	-32.66%	-82.22%